Cardiovascular Revascularization Medicine
Volume 7, Issue 2 , Pages 70-75, April 2006

IVUS-based dosimetry on patients with repeat-radiated coronary arteries to the same site

  • Christian Dilcher

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA
  • ,
  • Rosanna Chan

      Affiliations

    • Radiation Oncology Department, Washington Hospital Center, Washington, DC 20010, USA
  • ,
  • Ron Waksman

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 202 877 2812; fax: +1 202 877 2715.

Received 5 December 2005; accepted 5 December 2005.

Abstract 

Background and Purpose

Intracoronary radiation reduces recurrent in-stent restenosis (ISR). Repeat radiation may become necessary due to recurrent ISR. This study reports outcome-related dose calculations for twice-radiated coronary artery segments.

Materials and Methods

A total of 22 patients with angiographic evidence of ISR in a previously treated native coronary artery were assigned for repeat percutaneous coronary intervention and intravascular brachytherapy (IVBT). Intravascular brachytherapy was performed either with a 192Ir- or a 90Sr/Y-source (prescription dose: 14–18 and 23 Gy each at 2 mm from the center of the source), or a 32P-source (20 Gy 1-mm deep to the vessel wall). The mean time interval between the two IVBT treatments was 394±306 days. For each patient, angiograms and intravascular ultrasound cross sections were reviewed, on the basis of anatomical landmarks, matched, and the twice-radiated vessel segment identified.

Results

Clinical follow-up at 379±146 days revealed a target vessel revascularization rate of 18.2% and a target lesion revascularization rate of 13.6%. One death was reported. Maximal dose and average dose at the endothelium were 261 and 124±72.3 Gy, and maximal dose and average dose at the adventitia–media border were 159 and 50.3±29.3 Gy. Fourteen patients had 1.71 times longer recurrence-free interval compared to the interval between both IVBT treatments.

Conclusions

Repeat IVBT to the same ISR site is safe without any adverse clinical events at an average 12 months' follow-up. A second IVBT treatment led to a prolonged ISR-free survival for the majority of patients. The choice of isotope did not influence outcome.

Keywords: Dosimetry, Radiation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1553-8389(05)00194-6

doi:10.1016/j.carrev.2005.12.002

Cardiovascular Revascularization Medicine
Volume 7, Issue 2 , Pages 70-75, April 2006